MT Newswires6d agobearish
Teladoc Health Q2 Loss Widens, Revenue Falls; 2026 Guidance UpdatedTeladoc Health (TDOC) reported a Q2 loss late Wednesday of $0.21 per diluted share, wider than a los
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
531last 24h
2509last 7d
477● bullish (7d)
255● bearish (7d)
197publishers
24/7 Wall St.79d agobearish
Forget Hims. Its CEO Dumped 436,000 Shares Before a 1,266% Earnings Miss. Here Is the Profitable Healthcare Stock to Own InsteadHims & Hers (NYSE:HIMS) is dominating headlines this week because the GLP-1 darling just delivered one of the ugliest quarters in the telehealth sector’s short history, and bargain hunters are circling the wreckage. But here’s what you should actually be watching. The Q1 2026 release on May 11, 2026 was a fracture. EPS came in ... Forget Hims. Its CEO Dumped 436,000 Shares Before a 1,266% Earnings Miss. Here Is the Profitable Healthcare Stock to Own Instead